⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BSX News
Boston Scientific Corp.
Emboline Announces Positive Pivotal PROTECT H2H Trial Results for Emboliner® Presented as a Late-Breaking Clinical Trial at ACC 2026 USA - English USA - English
prnewswire.com
BSX
Pomerantz LLP Issues Reminder to Shareholders in Boston Scientific Corporation of Class Action Lawsuit – BSX
accessnewswire.com
BSX
BSX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Boston Scientific Corporation Shareholders Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
BSX
Boston Scientific receives FDA clearance for the Asurys™ Fluid Management System
prnewswire.com
BSX
Form 8-K
sec.gov
BSX
INVESTOR ALERT: Boston Scientific Corporation (BSX) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – RGRD Law
globenewswire.com
BSX
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - BSX
accessnewswire.com
BSX
Pomerantz LLP Informs Investors of Securities Class Action Against Boston Scientific Corporation – BSX
accessnewswire.com
BSX
Bronstein, Gewirtz & Grossman LLC Urges Boston Scientific Corporation Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
BSX
Pomerantz LLP Informs Investors of Class Action Filing Against Boston Scientific Corporation – BSX
accessnewswire.com
BSX